Astrana Health Inc (ASTH)
Return on equity (ROE)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 43,149 | 62,456 | 68,421 | 62,420 | 60,717 | 45,761 | 49,688 | 47,917 | 49,049 | 65,419 | 73,712 | 74,971 | 73,858 | 70,145 | 52,579 | 46,965 | 37,866 | 34,536 | 21,527 | 18,028 |
| Total stockholders’ equity | US$ in thousands | 712,720 | 704,616 | 678,874 | 653,490 | 614,218 | 593,714 | 566,012 | 560,044 | 542,561 | 510,438 | 479,966 | 473,985 | 454,550 | 435,897 | 401,360 | 349,091 | 330,824 | 228,404 | 207,023 | 197,080 |
| ROE | 6.05% | 8.86% | 10.08% | 9.55% | 9.89% | 7.71% | 8.78% | 8.56% | 9.04% | 12.82% | 15.36% | 15.82% | 16.25% | 16.09% | 13.10% | 13.45% | 11.45% | 15.12% | 10.40% | 9.15% |
December 31, 2024 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $43,149K ÷ $712,720K
= 6.05%
Astrana Health Inc's Return on Equity (ROE) fluctuated over the period from March 31, 2020, to December 31, 2024. The ROE started at 9.15% in March 2020 and gradually increased to reach a peak of 16.25% by December 2021. This indicated that the company was generating a higher profit relative to its shareholders' equity during this period.
However, from March 31, 2022, to December 31, 2024, the ROE experienced a decreasing trend. The ROE dropped to 6.05% by the end of December 2024, reflecting a decline in the company's profitability relative to its equity base. This downturn in ROE could be a cause for concern as it suggests a decrease in the efficiency of generating profits from shareholders' investments.
It is essential for Astrana Health Inc to analyze the factors contributing to the decline in ROE and take necessary strategic actions to improve profitability and efficiency in order to enhance shareholder value in the future.
Peer comparison
Dec 31, 2024